Company GSK plc

Equities

GSK

GB00BN7SWP63

Pharmaceuticals

Market Closed - London S.E. 11:35:10 2024-07-22 EDT 5-day change 1st Jan Change
1,524 GBX +0.13% Intraday chart for GSK plc +1.77% +5.12%

Business Summary

GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. Its product areas include vaccines, specialty medicines, and general medicine. It is also focused on addressing the unmet treatment needs of patients with respiratory and inflammatory conditions. Its vaccine portfolio includes over 20 vaccines that help to protect people from a range of diseases and infections, including meningitis, shingles and flu, among others. Its specialty medicines are also engaged in developing medicines for respiratory disease and HIV. Its general medicines include inhaled medicines for asthma and chronic obstructive pulmonary disease, antibiotics, and medicines for skin diseases. It is advancing oligonucleotide therapeutics in chronic hepatitis B and steatotic liver disease as well as other therapeutic areas beyond liver disease.

Number of employees: 70,212

Sales per Business

GBP in Million2022Weight2023Weight Delta
Commercial Operations
100.0 %
29,324 100.0 % 30,328 100.0 % +3.42%

Sales per region

GBP in Million2022Weight2023Weight Delta
United States
52.2 %
14,542 49.6 % 15,820 52.2 % +8.79%
Rest of World
45.6 %
14,087 48.0 % 13,815 45.6 % -1.93%
United Kingdom
2.3 %
695 2.4 % 693 2.3 % -0.29%

Managers

Managers TitleAgeSince
Chief Executive Officer 55 10-04-30
Director of Finance/CFO 62 23-04-30
Compliance Officer - 95-07-31
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 17-12-31
Chief Tech/Sci/R&D Officer - 17-07-31
Director/Board Member 62 17-12-31
Corporate Officer/Principal 57 93-12-31
Corporate Officer/Principal - 10-08-31
Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Director of Finance/CFO 62 23-04-30
Chairman 66 19-08-31
Director/Board Member 62 17-12-31
Director/Board Member 57 22-07-17
Director/Board Member 58 23-09-30
Director/Board Member 65 20-04-30
Director/Board Member 62 21-05-05
Chief Executive Officer 55 10-04-30
Director/Board Member 66 22-08-31
Director/Board Member 72 15-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 4,314,215,315 4,078,378,712 ( 94.53 %) 169,171,155 ( 3.921 %) 94.53 %

Shareholders

NameEquities%Valuation
Gsk Plc Employee Share Ownership Trust
4.777 %
198,015,976 4.777 % 3 829 M p
The Vanguard Group, Inc.
3.900 %
161,658,000 3.900 % 3 126 M p
BlackRock Fund Advisors
2.997 %
124,220,858 2.997 % 2 402 M p
Dodge & Cox
2.398 %
99,377,874 2.398 % 1 921 M p
Norges Bank Investment Management
2.023 %
83,873,000 2.023 % 1 622 M p
Schroder Investment Management Ltd.
1.799 %
74,577,180 1.799 % 1 442 M p
Legal & General Investment Management Ltd.
1.587 %
65,773,145 1.587 % 1 272 M p
Silchester International Investors LLP
1.244 %
51,544,866 1.244 % 997 M p
SSgA Funds Management, Inc.
1.148 %
47,592,191 1.148 % 920 M p
SIX SIS Ltd.
1.108 %
45,932,000 1.108 % 888 M p
NameEquities%Valuation
Dodge & Cox
3.323 %
68,862,308 3.323 % 2 651 M p
Fidelity Management & Research Co. LLC
1.186 %
24,581,222 1.186 % 946 M p
JTC Employer Solutions Trustee Ltd.
1.008 %
20,880,424 1.008 % 804 M p
Fisher Asset Management LLC
0.7560 %
15,668,260 0.7560 % 603 M p
PRIMECAP Management Co.
0.6146 %
12,738,370 0.6146 % 490 M p
Eaton Vance Management
0.6017 %
12,471,037 0.6017 % 480 M p
T. Rowe Price International Ltd.
0.5532 %
11,465,413 0.5532 % 441 M p
RBC Private Counsel (USA), Inc.
0.4918 %
10,192,106 0.4918 % 392 M p
Holocene Advisors, LP
0.4207 %
8,719,644 0.4207 % 336 M p
6,958,951 0.3358 % 268 M p
NameEquities%Valuation
Professionals’ Financial – Mutual Funds Inc.
0.000242 %
40,110 0.000242 % 573 879 p
Matrix Capital Management Trust reg.
0.000034 %
5,600 0.000034 % 80 123 p

Holdings

NameEquities%Valuation
127,054,524 75.00% 4,041,214,351 $
385,320,110 4.22% 1,571,331,555 $
263,029,794 82.59% 135,946,949 $
100,423,259 85.79% 107,304,261 $
8,550,954 6.28% 76,103,491 $
13,983,761 11.42% 69,778,967 $
16,591,937 7.40% 56,412,586 $
76,161,378 91.20% 45,811,069 $
30,253,189 11.87% 43,867,124 $
722,016 8.17% 32,992,954 $

Company contact information

GSK Plc

980 Great West Road Brentford

TW8 9GS, Middlesex

+44 20 8047 5000

http://www.gsk.com
address GSK plc(GSK)

Group companies

NameCategory and Sector
GlaxoSmithKline Capital Plc
Finance/Rental/Leasing
Biotechnology
Miscellaneous Commercial Services
Beverages: Alcoholic
Pharmaceuticals: Major
Pharmaceuticals: Major
GlaxoSmithKline Finance Plc
Finance/Rental/Leasing
Financial Conglomerates
Pharmaceuticals: Major

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
15.24 GBP
Average target price
19.85 GBP
Spread / Average Target
+30.22%
Consensus